Aurinia Pharmaceuticals Statistics
Total Valuation
AUPH has a market cap or net worth of $2.08 billion. The enterprise value is $1.77 billion.
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, before market open.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AUPH has 129.94 million shares outstanding. The number of shares has decreased by -5.13% in one year.
| Current Share Class | 129.94M |
| Shares Outstanding | 129.94M |
| Shares Change (YoY) | -5.13% |
| Shares Change (QoQ) | +1.58% |
| Owned by Insiders (%) | 0.95% |
| Owned by Institutions (%) | 60.99% |
| Float | 130.61M |
Valuation Ratios
The trailing PE ratio is 7.75 and the forward PE ratio is 19.72.
| PE Ratio | 7.75 |
| Forward PE | 19.72 |
| PS Ratio | 7.40 |
| Forward PS | 6.34 |
| PB Ratio | 3.73 |
| P/TBV Ratio | 3.62 |
| P/FCF Ratio | 15.46 |
| P/OCF Ratio | 15.43 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 13.04, with an EV/FCF ratio of 13.07.
| EV / Earnings | 6.16 |
| EV / Sales | 6.25 |
| EV / EBITDA | 13.04 |
| EV / EBIT | 15.23 |
| EV / FCF | 13.07 |
Financial Position
The company has a current ratio of 5.25, with a Debt / Equity ratio of 0.13.
| Current Ratio | 5.25 |
| Quick Ratio | 4.70 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.55 |
| Debt / FCF | 0.55 |
| Interest Coverage | 26.85 |
Financial Efficiency
Return on equity (ROE) is 59.91% and return on invested capital (ROIC) is 66.31%.
| Return on Equity (ROE) | 59.91% |
| Return on Assets (ROA) | 11.16% |
| Return on Invested Capital (ROIC) | 66.31% |
| Return on Capital Employed (ROCE) | 17.67% |
| Weighted Average Cost of Capital (WACC) | 12.35% |
| Revenue Per Employee | $2.21M |
| Profits Per Employee | $2.24M |
| Employee Count | 128 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 1.53 |
Taxes
| Income Tax | -173.05M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +96.09% in the last 52 weeks. The beta is 1.52, so AUPH's price volatility has been higher than the market average.
| Beta (5Y) | 1.52 |
| 52-Week Price Change | +96.09% |
| 50-Day Moving Average | 14.98 |
| 200-Day Moving Average | 13.69 |
| Relative Strength Index (RSI) | 56.16 |
| Average Volume (20 Days) | 1,061,150 |
Short Selling Information
The latest short interest is 9.11 million, so 7.01% of the outstanding shares have been sold short.
| Short Interest | 9.11M |
| Short Previous Month | 10.81M |
| Short % of Shares Out | 7.01% |
| Short % of Float | 6.98% |
| Short Ratio (days to cover) | 7.70 |
Income Statement
In the last 12 months, AUPH had revenue of $283.06 million and earned $287.20 million in profits. Earnings per share was $2.07.
| Revenue | 283.06M |
| Gross Profit | 217.89M |
| Operating Income | 116.26M |
| Pretax Income | 114.16M |
| Net Income | 287.20M |
| EBITDA | 135.71M |
| EBIT | 116.26M |
| Earnings Per Share (EPS) | $2.07 |
Full Income StatementBalance Sheet
The company has $397.94 million in cash and $74.81 million in debt, giving a net cash position of $323.13 million or $2.49 per share.
| Cash & Cash Equivalents | 397.94M |
| Total Debt | 74.81M |
| Net Cash | 323.13M |
| Net Cash Per Share | $2.49 |
| Equity (Book Value) | 581.33M |
| Book Value Per Share | 4.39 |
| Working Capital | 398.24M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $135.66 million and capital expenditures -$252,000, giving a free cash flow of $135.41 million.
| Operating Cash Flow | 135.66M |
| Capital Expenditures | -252,000 |
| Depreciation & Amortization | 19.45M |
| Net Borrowing | -13.14M |
| Free Cash Flow | 135.41M |
| FCF Per Share | $1.04 |
Full Cash Flow StatementMargins
Gross margin is 76.98%, with operating and profit margins of 41.07% and 101.47%.
| Gross Margin | 76.98% |
| Operating Margin | 41.07% |
| Pretax Margin | 40.33% |
| Profit Margin | 101.47% |
| EBITDA Margin | 47.94% |
| EBIT Margin | 41.07% |
| FCF Margin | 47.84% |
Dividends & Yields
AUPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.13% |
| Shareholder Yield | 5.13% |
| Earnings Yield | 13.72% |
| FCF Yield | 6.47% |
Analyst Forecast
The average price target for AUPH is $17.25, which is 7.54% higher than the current price. The consensus rating is "Buy".
| Price Target | $17.25 |
| Price Target Difference | 7.54% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 14.42% |
| EPS Growth Forecast (5Y) | 1.77% |
Stock ForecastsStock Splits
The last stock split was on October 23, 2013. It was a reverse split with a ratio of 1:50.
| Last Split Date | Oct 23, 2013 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
AUPH has an Altman Z-Score of 5.22 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.22 |
| Piotroski F-Score | 5 |